Structural characterization of γδ-TCR-ligand interaction

γδ-TCR-配体相互作用的结构表征

基本信息

  • 批准号:
    470667900
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    德国
  • 项目类别:
    Research Units
  • 财政年份:
  • 资助国家:
    德国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The mechanisms, how γδ TCRs interact with their cognate antigen remain poorly understood in spite of the rising interest in γδ T cells and their crucial role in the immune response. One of the main reasons for this gap in understanding is the limited number of identified γδ TCR / ligand pairs and the resulting small number of available structures of γδ TCRs in complex with their respective ligand.In this project, we will structurally characterize the molecular interaction between γδ TCRs and their cognate ligand by X-ray crystallography using a specific Vγ3Vδ1+ TCR / HLA-DR (MHC class II) pair that was identified by the Prinz group in the previous funding period of FOR 2799. To this end, we will recombinantly express important amounts of soluble ectodomains from three TCR variants that are expected to bind the same ligand but with different binding affinity. We will also express important amounts of a soluble HLA-DR ectodomain in insect cells. Since HLA as MHC class II molecule requires interaction with a peptide for folding and stabilization, we will produce the latter as a fusion protein with various peptides to be presented. We will assemble complexes from the recombinant proteins, crystallize these complexes, determine the structure using X-ray crystallography and thereby identify the main determinants of this interaction. The expression of the HLA-DR in fusion with peptides will also enable us to structurally characterize the role of the peptide using various HLA-DR / peptide combinations. This structural analysis will be complemented by a thorough biochemical analysis of this interaction that will provide detailed kinetic binding parameters of the TCR variants to a number of HLA / peptide combinations.In summary, this project aims to considerably advance the understanding of how γδ TCRs interact with their cognate antigen. The scientific environment of the DFG Research Unit FOR 2799 „Receiving and Translating Signals via the γδ T Cell Receptor“ will provide optimal conditions for a sustainable exchange and we will share our complementary biochemical and structural biology expertise with all members of the consortium to potentially identify additional γδ TCR / ligand pairs.
尽管人们对γδ T细胞及其在免疫应答中的关键作用越来越感兴趣,但γδ TCR如何与其同源抗原相互作用的机制仍然知之甚少。这种理解上的差距的主要原因之一是所鉴定的γδ TCR /配体对的数量有限,并且由此产生的γδ TCR与其相应配体复合的可用结构的数量很少。我们将使用特异性Vγ3Vδ1+ TCR / HLA-DR通过X射线晶体学来表征γδ TCR与其同源配体之间的分子相互作用。(MHC II类)对,这是由Prinz集团在前一个供资期为2799确定的。为此,我们将重组表达来自三种TCR变体的重要量的可溶性胞外域,所述TCR变体预期结合相同的配体但具有不同的结合亲和力。我们还将在昆虫细胞中表达大量的可溶性HLA-DR胞外域。由于HLA作为MHC II类分子需要与肽相互作用以进行折叠和稳定化,我们将产生后者作为与待呈递的各种肽的融合蛋白。我们将从重组蛋白组装复合物,结晶这些复合物,确定结构使用X射线晶体学,从而确定这种相互作用的主要决定因素。与肽融合的HLA-DR的表达也将使我们能够使用各种HLA-DR /肽组合在结构上表征肽的作用。该结构分析将通过对这种相互作用的全面生化分析来补充,该分析将提供TCR变体与许多HLA /肽组合的详细动力学结合参数。总之,该项目旨在大大推进对γδ TCR如何与其同源抗原相互作用的理解。DFG Research Unit FOR 2799“通过γδ T细胞受体接收和翻译信号”的科学环境将为可持续的交流提供最佳条件,我们将与联盟的所有成员分享我们互补的生物化学和结构生物学专业知识,以潜在地识别更多的γδ TCR /配体对。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Thomas Krey其他文献

Professor Dr. Thomas Krey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Thomas Krey', 18)}}的其他基金

Development of germline-targeting HCV E2 immunogens to drive neutralizing antibody evolution
开发种系靶向 HCV E2 免疫原以驱动中和抗体进化
  • 批准号:
    436187515
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Structural and functional characterization of the chemokine enhancing activity ofvaricella zoster virus (VZV) glycoprotein C
水痘带状疱疹病毒 (VZV) 糖蛋白 C 趋化因子增强活性的结构和功能表征
  • 批准号:
    405772731
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Structure-based design of an epitope-focused Hepatitis C virus vaccine
基于表位的丙型肝炎病毒疫苗的结构设计
  • 批准号:
    323016498
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Role of Kaposi’s sarcoma-associated herpesvirus complement control protein in cell migration and angiogenesis
卡波西肉瘤相关疱疹病毒补体控制蛋白在细胞迁移和血管生成中的作用
  • 批准号:
    500627539
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Elicitation of antibodies broadly neutralizing the porcine reproductive and respiratory syndrome virus (PRRSV) using reverse vaccinology
使用反向疫苗学诱导广泛中和猪繁殖与呼吸综合征病毒 (PRRSV) 的抗体
  • 批准号:
    511670106
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Detection and characterization of dual-TCR T cells
双 TCR T 细胞的检测和表征
  • 批准号:
    21K19371
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development & Characterization of Tyrosinase Epitope Specific TCR Transgenic Mice
发展
  • 批准号:
    7808041
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Isolation and Characterization of Prostrate Antigen Specific High Affinity TCR
前列腺抗原特异性高亲和力 TCR 的分离和表征
  • 批准号:
    7572466
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Development & Characterization of Tyrosinase Epitope Specific TCR Transgenic Mice
发展
  • 批准号:
    7589415
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Characterization of the polyclonal TCR repertoire in TCR-beta transgenic mice
TCR-β 转基因小鼠多克隆 TCR 库的表征
  • 批准号:
    7922913
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Characterization of the polyclonal TCR repertoire in TCR-beta transgenic mice
TCR-β 转基因小鼠多克隆 TCR 库的表征
  • 批准号:
    7408628
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Characterization of the polyclonal TCR repertoire in TCR-beta transgenic mice
TCR-β 转基因小鼠多克隆 TCR 库的表征
  • 批准号:
    7255123
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Functional Characterization of Two Distinct TCR Beta Genes of Teleosts
硬骨鱼两个不同 TCR β 基因的功能特征
  • 批准号:
    0211785
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
CHARACTERIZATION OF TCR Vβ RESPONSE TO CANCER ANTIGEN PEPTIDE
TCR Vβ 对癌抗原肽反应的表征
  • 批准号:
    13671347
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了